If we take the post-market adverse event report for pharmaceuticals, from any source, whether they come from the manufacturers or consumers or health care professionals, they will all end up in the same area, which is the Canada Vigilance database. This is where the Canadian reports will be collated. It's also in that same area that the international reports are kept in the records. So if we're talking about drugs, it all ends up in the same place.
On May 1st, 2008. See this statement in context.